Shares of German automaker, BMW (BMW.DE) slumps today almost 9% on unexpected FY2024 guidance cut, affected especially by slowing demand on Chinese market. What's more, the company grapples with technical problems of Integrated Braking System (IBS), supplied by its external partner for 1.5 million cars fleet.
- Now, BMW has to halt deliveries of cars that haven't reached customers yet, which will probably end with lower sales in 2024 and even hundred million euros additional costs impacting earnings report since Q3 2024. However, BMW expects that Q3 will be impacted much more than Q4.
- The German automaker expects now slight decrease in 2024 deliveries; previously awaited modest growth. EBIT margin in the automotive segment is now expected to fall to narrow to a range of 6% to 7%, vs previously anticipated 8% to 10%. Also, ROCE for the automotive business will be probably between 11% and 13%, below the earlier 2024 target of 15% to 20%.
- The company still expects 4 billion EUR free cash flows for the year, but profitability pressure persists. Also, motorcycle segment is now weaker than expected, due to slowing US and Chinese markets. BMW expects flat year-on-year deliveries and the EBIT margin forecast of motorcycle business has been also revised down to 6% to 7%, from the previously expected 8% to 10% range, with ROCE between 14 to 16% (21% to 26% previously).
BMW.DE chart (D1 interval)
The discount between BMW shares and major resistance zone of EMA200 (the red line) is now more than 30% (bearish trend) but RSI dropped today to 17 points, signalling oversold conditions.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.